Conversation with The Cancer Letter

Conversation with The Cancer Letter

FDA spells out new systematic approach to giving out–and taking away–accelerated approvals in oncology
Conversation with The Cancer Letter

FDA spells out new systematic approach to giving out–and taking away–accelerated approvals in oncology

Companies vying for accelerated approval and devising strategies for confirmatory trials would be best served by seeking prospective sign-off from FDA, agency officials say.  Officials from the FDA Oncology Center of Excellence described these best practices in a perspective piece in the Sept. 21 issue of The New England Journal of Medicine and discussed the […]
Ohio State’s Alice Mims: Six-week abortion ban places oncologists in jeopardy
Conversation with The Cancer LetterFree

Ohio State’s Alice Mims: Six-week abortion ban places oncologists in jeopardy

As conservative legislatures take the cue from the Supreme Court’s overturn of Roe v. Wade by enacting abortion restrictions, oncologists in many states are scrambling to figure out how to best care for their pregnant patients, said Alice Mims, a hematologist-oncologist at the Ohio State University Comprehensive Cancer Center – James.